- £3.60bn
- £4.86bn
- $3.35bn
UK Stocks-Factors to watch on February 5 (updated)
UK Stocks-Factors to watch on February 5
Brookfield rules out offer for UK's Hikma
Brookfield Pvt.Cap. Hikma Pharmaceutical - Statement regarding Hikma Pharmaceuticals Plc
Hikma Pharmaceutical - Notice of Results
Brief: Hikma Launches Enoby And Xtrenbo Referencing Prolia And Xgeva Respectively
US Supreme Court to hear 'skinny label' patent fight involving Amarin (updated)
US Supreme Court to hear 'skinny label' patent fight involving Amarin
Hikma slips after Barclays downgrades stock
Hikma Pharmaceutical - Director/PDMR Shareholding
Hikma Pharmaceutical - Director/PDMR Shareholding
Hikma Pharmaceutical - Director/PDMR Shareholding
Live Markets: Before the bell: Europe up, defence and weed stocks eyed
UK Stocks-Factors to watch on December 15 (updated)
Brief: Hikma CEO Riad Mishlawi Steps Down
UK's Hikma CEO Riad Mishlawi steps down (updated)
Hikma's CEO Riad Mishlawi steps down
Hikma Pharmaceutical - Hikma announces CEO change and Board appointment
Brief: Hikma Launches Tyzavan In The US